Find practical information about diabetes treatment and management, including blood sugar monitoring, medications, lifestyle changes, complications and everyday diabetes care.
Research by Voiant and University of Turin scientists suggests pre-treatment retinal scans could help predict changes in patients’ vision and retinal thickness. Voiant said a collaboration with researchers in Turin has published work suggesting machine-learning tools may help predict how…
A reading of 278 mg/dL is significantly above normal. Find out when to retest, what may be driving the spike and which symptoms require immediate medical help. A single blood sugar reading of 278 mg/dL should not be brushed aside,…
The familiar pairing brings fibre, antioxidants and natural sweetness, but cinnamon is no cure-all and the type used matters. Apples and cinnamon are often treated as a simple comfort food pairing, but the combination can do more than add flavour…
Mouse experiments suggest that eating fat before carbohydrates may moderate post-meal glucose rises through a combination of delayed gastric emptying, gut hormones and vagus nerve signals, but human trials are still needed. A study in mice suggests that the order…
Small, frequent meals, cooler foods and careful hydration may help people manage nausea after GLP-1 injections or dose increases, while severe symptoms need medical advice. Nausea is one of the most common complaints among people taking GLP-1 medicines such as…
Four endocrinologists recommend whole fruit in sensible portions, paired with foods such as yoghurt, nuts or cheese, rather than avoiding naturally sweet options. Four endocrinologists say fruit does not need to be treated as a threat to blood sugar, so…
A new prediction model combining routine blood measures and fat tissue hormones aims to identify type 2 diabetes patients at risk of developing sight-threatening retinopathy earlier, though further validation is needed. Researchers in China have built a prediction model that…
New analyses from the Phase 3 ATTAIN-1 trial suggest that Eli Lilly’s oral GLP-1 medicine Foundayo could lower predicted long-term risks of type 2 diabetes and cardiovascular disease, marking a potential breakthrough in obesity and cardiometabolic treatment. Eli Lilly’s oral…
Boehringer Ingelheim reports encouraging data from late-stage trials of survodutide, an experimental weekly injection demonstrating significant weight and glycemic improvements in participants with obesity and type 2 diabetes, with ongoing efforts to optimise tolerability and understand body composition effects. Boehringer…
Doctors warn that patients taking unapproved peptide medications or GLP-1 injections like Ozempic must inform their anaesthetist prior to surgery to prevent serious complications, as new research links these drugs to increased regurgitation and aspiration risks. Patients who are taking…
Emerging evidence highlights exercise not just as lifestyle advice but as a recognised and essential part of long-term disease management, tailored to individual needs to optimise health outcomes. Exercise is increasingly being treated as more than a lifestyle choice in…
While GLP-1 receptor agonists are revolutionising obesity treatment, clinicians emphasise that sustained success hinges on diet, exercise, and long-term behavioural changes, as recent studies and patient experiences highlight the importance of a comprehensive approach. GLP-1 medicines may have transformed weight-loss…
